Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02506829 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Treatment
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT02506829 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 182 participants.
The verdict
NCT02506829, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-net role for urban veterans. During hospitalization, all smokers will receive usual care. Patients will be randomized to one of two arms: financial incentives plus usual care vs. usual care alone, which includes referral to the state Quitline. All patients enrolled in the study will be offered nicotine replacement therapy. The investigators will conduct follow-up assessments at 2 weeks, 2 months, 6 months and 12 months after discharge. The primary study outcome is smoking abstinence at 6-month follow-up, verified by salivary/urinary cotinine.
Interventions
- BEHAVIORAL Financial incentives
- BEHAVIORAL Smoking cessation counseling (Quitline)
- BEHAVIORAL Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02506829
The ClinicalTrials.gov registry entry for NCT02506829 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Financial incentives is the first listed.
NCT02506829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02506829 about?
NCT02506829 is a clinical study titled "Financial Incentives for Smoking Treatment". The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-n...
What is the current status of trial NCT02506829?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2015-07. Estimated completion is 2019-05-20.
What interventions are being tested in trial NCT02506829?
The interventions under investigation include: Financial incentives (BEHAVIORAL), Smoking cessation counseling (Quitline) (BEHAVIORAL), Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02506829?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.